Clinical Trial Update: Clinical Tolerance of Numeta 13%

View source ↗

Summary

A clinical trial update from the University of Liege reports on the tolerability of Numeta 13% in preterm/neonatal infants; the current status of the trial is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Mineral Metabolism
• Failure to Thrive

Drugs mentioned

• Numeta 13% (neonatal parenteral nutrition solution (amino acids, dextrose, lipids))

Snippet

Sponsor: University of Liege | Conditions: Other Preterm Infants, Transitory Neonatal Electrolyte Disturbance | Status: UNKNOWN